Literature DB >> 9915710

Di Bella's therapy: the last word? The evidence would be stronger if the researchers had randomised their studies.

M Müllner.   

Abstract

Mesh：

Year:  1999        PMID： 9915710      PMCID： PMC1114705          DOI： 10.1136/bmj.318.7178.208

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Unbiased, relevant, and reliable assessments in health care: important progress during the past century, but plenty of scope for doing better.

Authors:  I Chalmers
Journal:  BMJ       Date:  1998-10-31

Review 2.  Understanding controlled trials. Why are randomised controlled trials important?

Authors:  B Sibbald; M Roland
Journal:  BMJ       Date:  1998-01-17

3.  Italy starts trials for controversial cancer treatment.

Authors:  F Turone
Journal:  BMJ       Date:  1998-01-31

4.  The group sequential triangular test for phase II cancer clinical trials.

Authors:  E Bellissant; J Bénichou; C Chastang
Journal:  Am J Clin Oncol       Date:  1996-08       Impact factor: 2.339

5.  Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy. Italian Study Group for the Di Bella Multitherapy Trails.

Authors: 
Journal:  BMJ       Date:  1999-01-23
  5 in total
  2 in total

1.  The Di Bella multitherapy trial. Randomised controlled trials may not always be absolutely needed.

Authors:  A Liberati; N Magrini; L Patoia; L Pagliaro
Journal:  BMJ       Date:  1999-04-17

2.  Science under politics. An Italian nightmare.

Authors:  Elena Cattaneo; Gilberto Corbellini
Journal:  EMBO Rep       Date:  2010-12-10       Impact factor: 8.807
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.